Introduction Pregabalin is a chemical analog of the neurotransmitter gamma-aminobutyric acid (GABA). Its anticonvulsive, anxiolytics and analgetic effect is based on reducing of quantity of several neurotransmitters – especially glutamate, noradrenaline and substance P. Objective Generalized anxiety disorder is a quite common psychiatric disorder, affecting approximately 8% of the population. Pregabalin is effective in the treatment of GAD. Its efficacy is comparable to sertraline. The first positive effects on symptoms of anxiety are described after one week of an admistrating. Anxiolytic dose of pregabaline varies from 450 to 600mg per day. Pregabalin could be used potentially in patients with benzodiazepines adictions. There is hypothesis that pregabaline moderates withdrawal symptoms. Aims This poster presents a case report of the patient who suffers from generalized anxiety disorder with comorbid somatoform disorder and severe hypnotic (zolpidem abuse) Methods Short-termed hospitalisation at the detoxification unit to reduce doses of zolpideme. The attempt to use pregabaline to treat an anxiety and to decrease withdrawal symptoms. Results Patient who has been treated by antidepressants without any effect so far, is now showing a good response to pregabalin. Conclusion Decreasing symptoms of anxiety and somatoform pain compared to the beginning of the treatment. Complete discontinuation of using zolpidem without the withdrawal symptoms.
Read full abstract